Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Inventory (2016 - 2025)

Cumberland Pharmaceuticals' Inventory history spans 16 years, with the latest figure at $6.2 million for Q4 2025.

  • For Q4 2025, Inventory rose 55.64% year-over-year to $6.2 million; the TTM value through Dec 2025 reached $6.2 million, up 55.64%, while the annual FY2025 figure was $6.2 million, 55.64% up from the prior year.
  • Inventory for Q4 2025 was $6.2 million at Cumberland Pharmaceuticals, up from $2.9 million in the prior quarter.
  • Across five years, Inventory topped out at $10.9 million in Q2 2023 and bottomed at $2.9 million in Q3 2025.
  • The 5-year median for Inventory is $8.7 million (2023), against an average of $7.5 million.
  • The largest annual shift saw Inventory crashed 60.63% in 2024 before it surged 55.64% in 2025.
  • A 5-year view of Inventory shows it stood at $8.4 million in 2021, then rose by 17.01% to $9.9 million in 2022, then decreased by 12.1% to $8.7 million in 2023, then tumbled by 53.87% to $4.0 million in 2024, then soared by 55.64% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Inventory are $6.2 million (Q4 2025), $2.9 million (Q3 2025), and $3.2 million (Q2 2025).